|
| |
BioPortfolio's Approved Drugs DatabaseTaxolPaclitaxelDownload PDF containing detailed information.
Press Releases About Taxol:
|
 |
| Updated NCCN Guidelines for Breast Cancer Discourages Prophylactic Mastectomy in Women Other Than Those at High Risk |
28th October, 2009 |
National Comprehensive Cancer Network |
The removal of a noncancerous breast (prophylactic mastectomy) is generally discouraged in women other than those at high risk as stated in the updated National Comprehensive Cancer Network (NCCN)
|
| Reportlinker Adds World Market for Cancer Therapeutics and Biotherapeutics, 3rd. Edition, The Report |
24th September, 2009 |
Reportlinker |
-- SERMS
The report includes market share by type of cancer and market share by company for each of the three major segments. It also includes statistical information for cancers by type
|
| OPAXIO(TM) Combined with Alimta(R) Well Tolerated in Dose-Ranging Study of Patients with Advanced Non-Small Cell Lung Cancer |
3rd August, 2009 |
Cell Therapeutics, Inc. |
SEATTLE, Aug. 3 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) announced results from a study released by Dartmouth-Hitchcock Medical Center at the International
|
| European Medicines Agency (EMEA) Approves Cell Therapeutics, Inc.'s September Meeting Request to Discuss OPAXIO(TM) Marketing Authorization Application |
7th July, 2009 |
Cell Therapeutics, Inc. |
SEATTLE, July 7 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. ("CTI") (Nasdaq and MTA: CTIC) announced today that it had requested and the EMEA has agreed to an oral explanation in
|
| Paclitaxel Poliglumex (OPAXIO(TM)) Added to Cisplatin and Radiation Produces 45% Pathologic Complete Remissions in Patients With Esophageal Cancer |
3rd June, 2009 |
Cell Therapeutics, Inc. |
Promising Preliminary Results on Radiation Sensitization from Phase II Trial May Serve as Additional Registration Direction for OPAXIO
ORLANDO, Fla., June 3 /PRNewswire-FirstCall/ -- Cell
|
Companies working in the area of Taxol from Bioportfolio's Biocorporate database : | |
| Company Name | |
The plant kingdom’s more than 250,000 species produce an amazing number of chemical entities, yet most of these entities have never been investigated for their medicinal properties. Although many high...
www.phytonbiotech.com/ View full profile
| |
Phyton Biotech is the pioneer of commercial plant cell fermentation for production of small molecules and is developing this technology to encompass recombinant proteins.
Therapies of the future ...
www.phytonbiotech.com/ View full profile
| |
The company was founded in 1961 to provide sample preparation products for electron microscopy as nano-scale samples were starting to reveal new knowledge. Embedding products were added for histology ...
www.polysciences.com/ View full profile
| | →View more Taxol related companies. |
This page has been viewed 30 times
Recent Search Terms used to find this page: .
Browse BioPortfolio's InDepth service - alphabetically:
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
or by Most Publications, recently searched for, or
most viewed.
Search for Taxol across BioPortfolio, or for Taxol Research Reports
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH.
Thumbshots from Thumbshots.org
|
